Guido Kroemer Selected Research

Guido Kroemer Research Topics

Disease

440	Neoplasms (Cancer) 10/2022 - 01/2002
35	Necrosis 01/2022 - 03/2004
30	Breast Neoplasms (Breast Cancer) 03/2022 - 09/2007
30	Carcinogenesis 01/2022 - 11/2003
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2004
26	Melanoma (Melanoma, Malignant) 01/2022 - 04/2006
24	Obesity 11/2021 - 07/2010
24	Carcinoma (Carcinomatosis) 01/2021 - 01/2002
23	Starvation 01/2022 - 11/2005
21	Inflammation (Inflammations) 05/2022 - 10/2011
21	Infections 01/2022 - 03/2002
18	Tetraploidy 11/2021 - 06/2006
18	Cystic Fibrosis (Mucoviscidosis) 12/2020 - 09/2013
17	Neoplasm Metastasis (Metastasis) 05/2021 - 08/2011
16	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2002
14	Hypoxia (Hypoxemia) 01/2021 - 07/2003
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 02/2006
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2008
10	Polyploidy 11/2017 - 09/2004
9	COVID-19 01/2022 - 01/2020
9	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 05/2012
8	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2004
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 12/2016
8	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020 - 01/2007
8	Ischemia 01/2020 - 07/2003
7	Mitochondrial Diseases (Mitochondrial Disease) 03/2022 - 01/2002
7	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 09/2012
7	Residual Neoplasm 01/2021 - 10/2007
6	Celiac Disease (Celiac Sprue) 12/2019 - 01/2019
5	Heart Failure 10/2022 - 12/2005
5	Weight Gain 04/2022 - 01/2017
5	Multiple Myeloma 03/2022 - 11/2013

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 03/2022 - 05/2003
50	AntigensIBA 01/2022 - 09/2007
41	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2007
37	AnthracyclinesIBA 01/2021 - 03/2007
33	CalreticulinIBA 01/2022 - 01/2007
33	Adenosine Triphosphate (ATP)IBA 01/2022 - 04/2004
32	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2004
29	VaccinesIBA 01/2022 - 09/2003
29	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2006
26	CytokinesIBA 01/2022 - 03/2002
24	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 09/2004
22	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
22	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
21	HMGB1 Protein (HMG1)IBA 01/2022 - 09/2007
19	Biomarkers (Surrogate Marker)IBA 03/2022 - 09/2007
19	Peptides (Polypeptides)IBA 01/2022 - 04/2006
17	InterferonsIBA 01/2022 - 02/2006
17	Phosphotransferases (Kinase)IBA 01/2021 - 01/2008
15	LigandsIBA 12/2021 - 03/2002
15	Monoclonal AntibodiesIBA 01/2021 - 01/2012
15	CaspasesIBA 12/2018 - 01/2002
12	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 09/2007
12	SpermidineIBA 01/2021 - 11/2009
11	5-methoxy-methylindoleacetic acid (DBI)IBA 04/2022 - 01/2019
10	Hormones (Hormone)IBA 01/2022 - 09/2006
10	CarcinogensIBA 01/2021 - 09/2012
10	Therapeutic UsesIBA 10/2020 - 12/2007
10	Apoptosis Inducing FactorIBA 01/2020 - 06/2003
9	Pattern Recognition ReceptorsIBA 01/2022 - 08/2009
9	AntibodiesIBA 01/2022 - 08/2011
9	LipidsIBA 11/2021 - 01/2008
9	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 08/2013
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 03/2012
8	EnzymesIBA 05/2022 - 11/2011
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 05/2004
8	PolyaminesIBA 11/2021 - 11/2009
8	InterleukinsIBA 01/2020 - 03/2010
8	InflammasomesIBA 01/2019 - 10/2009
8	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 03/2012
8	Toll-Like Receptor AgonistsIBA 01/2018 - 08/2012
8	Toll-Like Receptor 4IBA 02/2016 - 09/2007
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 07/2007
7	Transcription Factors (Transcription Factor)IBA 03/2022 - 03/2004
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
7	Histones (Histone)IBA 01/2021 - 06/2008
7	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2015
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 04/2004
7	Sirolimus (Rapamycin)FDA Link 10/2019 - 01/2006
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 07/2019 - 12/2016
7	ErbB Receptors (EGF Receptor)IBA 12/2014 - 07/2007
6	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 07/2010
6	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 11/2007
6	Interferon Type IIBA 01/2022 - 11/2014
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 02/2007
6	ChromatinIBA 01/2022 - 09/2004
6	CrizotinibIBA 01/2021 - 01/2019
6	Diazepam Binding InhibitorIBA 01/2021 - 10/2019
6	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2007
6	Glutens (Glutelin)IBA 12/2019 - 01/2019
6	GliadinIBA 12/2019 - 01/2019
6	Purinergic Receptors (Receptors, Purine)IBA 01/2019 - 10/2009

Therapy/Procedure

161	Therapeutics 03/2022 - 01/2002
96	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
69	Immunotherapy 01/2022 - 01/2008
31	Radiotherapy 01/2021 - 12/2006
9	Neoadjuvant Therapy 01/2021 - 09/2011
8	Caloric Restriction 03/2021 - 01/2010
6	Adjuvant Chemotherapy 06/2016 - 05/2012